4//SEC Filing
EYETECH PHARMACEUTICALS INC 4
Accession 0001293941-04-000021
CIK 0001115285operating
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 8:12 PM ET
Size
17.8 KB
Accession
0001293941-04-000021
Insider Transaction Report
Form 4
ALTSCHULER DOUGLAS H
Sr VP, Legal, General Counsel
Transactions
- Sale
Common Stock
2004-12-20$43.58/sh−8,000$348,640→ 333 total - Exercise/Conversion
Common Stock
2004-12-20$3.50/sh+2,976$10,416→ 3,309 total - Sale
Common Stock
2004-12-20$43.58/sh−2,976$129,694→ 333 total - Sale
Common Stock
2004-12-20$43.58/sh−21,024$916,226→ 333 total - Exercise/Conversion
Common Stock
2004-12-20$3.50/sh+21,024$73,584→ 21,357 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2004-12-20−2,976→ 17,262 totalExercise: $3.50From: 2004-07-07Exp: 2013-07-07→ Common Stock (2,976 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2004-12-20−21,024→ 105,405 totalExercise: $3.50From: 2004-07-07Exp: 2013-07-07→ Common Stock (21,024 underlying) - Award
Non-Qualified Stock Option (right to buy)
2004-12-09+25,000→ 25,000 totalExercise: $43.55From: 2005-12-09Exp: 2014-12-08→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option becomes exercisable with respect to the first 25% of the original number of shares on the first aniversary of the grant date (as specified in column 3) and an additional 2.08333% of the original number of shares at the end of each successive monthly period following the first anniversary of the grant date.
Documents
Issuer
EYETECH PHARMACEUTICALS INC
CIK 0001115285
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001115285
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 8:12 PM ET
- Size
- 17.8 KB